As defined by the NIH Guidelines, the NCI-Frederick Institutional Biosafety Committee
(NCI-F IBC) was established to provide local review and oversight of nearly all
forms of research utilizing recombinant DNA. The NCI-F IBC has also been charged
to review research being conducted with pathogens, oncogenes, human materials, biological
toxins, transgenic and/or knock-out/in animals and other potentially infectious material
that is being performed at or sponsored by the NCI-F.